TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 8.99
-0.18 (-1.96%)
Sep 8, 2026, 12:19 PM CST
TPEX:4157 Market Cap
TPEX:4157 has a market cap or net worth of 6.53 billion as of September 4, 2026. Its market cap has decreased by -6.16% in one year.
Market Cap
6.53B
Enterprise Value
5.62B
Revenue
256.46M
Ranking
n/a
PE Ratio
42.48
Stock Price
8.99
ChartMarket Cap Chart
Since September 5, 2013, TPEX:4157's market cap has decreased from 42.07B to 6.53B, a decrease of -84.48%. That is a compound annual growth rate of -13.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 6.53B | -31.57% |
| Dec 31, 2025 | 9.54B | 16.05% |
| Dec 31, 2024 | 8.22B | -24.67% |
| Dec 29, 2023 | 10.91B | -5.16% |
| Dec 30, 2022 | 11.51B | 4.22% |
| Dec 30, 2021 | 11.04B | -32.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Locus Cell | 8.09B |
| Adimmune | 7.40B |
| Acepodia | 7.05B |
| Savior Lifetec | 6.33B |
| Sinphar Pharmaceutical | 6.17B |
| Steminent Biotherapeutics | 6.16B |
| AnnJi Pharmaceutical | 5.82B |
| TWi Biotechnology | 5.53B |